U.S. Firm Expands Sales Team to Promote Honey Wound Care Product

Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008

PRINCETON, N.J., Jan. 18 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. , a provider of advanced wound care products, said that it has increased its direct-sales staff significantly, based on a number of new products that are finding favor in target markets. The company, which had only two direct salespersons in the US a year ago, now has nine, and will move to 21 by 2009.

The increase is a significant one for Derma Sciences, which has been growing sales at an accelerating rate, and which has introduced several new products over the last couple of years. Most recently, the company launched MEDIHONEY(TM) Calcium Alginate with Active Leptospermum Honey. This product, along with several line extensions to be launched in 2008, is covered under several patents.

Chairman and CEO Ed Quilty commented, "MEDIHONEY has made quite a stir since we introduced it a few months back, and we are looking forward to it as a strong lead product for the sales force. Expanding our sales force allows us to maximize the opportunity, and also broadens the coverage of our entire product line of advanced wound-care products. We will be detailing wound-care centers, nursing homes, hospitals and medical specialists…

MEDIHONEY is the first honey-based product marketed in the US for advanced wound care, although similar products have been marketed in the UK and Europe for some time. It is comprised primarily of active Leptospermum honey, which is noted for its effects on wound healing and burn management. Derma Sciences also supplies products such as the antimicrobial silver-based ALGICELL(TM) Ag and a variety of additional proprietary wound-healing products…